ITHERA SCIENTIFIC GMBH

Their core work

iThera Scientific is a Munich-based SME that develops and applies photoacoustic (optoacoustic) imaging technology for biomedical research. Their core capability is visualizing biological processes deep inside living tissue by combining light excitation with acoustic detection — a technique that avoids ionizing radiation and operates at tissue depths beyond conventional optical microscopy. In H2020 projects they contributed this imaging expertise to research on pancreatic islet transplantation for diabetes (iNanoBIT) and nanostar-enhanced imaging of stem cell therapy for arthritic joints (STARSTEM). They work at the intersection of nanotechnology and advanced biomedical imaging, providing both the imaging instruments and the technical knowledge to integrate them into complex research workflows.

What they specialise in

How they've shifted over time

In their earlier H2020 work (iNanoBIT, 2017), iThera Scientific supported a broad spectrum of imaging modalities — NMR, SPECT, PET, CT, and acoustic imaging — in the context of diabetes and pancreatic islet transplantation, suggesting a role as a general multi-modal imaging technology provider. Their later project (STARSTEM, 2018) shows a clear narrowing toward photoacoustic imaging specifically, combined with engineered nanoparticle contrast agents (nanostars) and targeted at deep-tissue visualization for stem cell therapy in arthritic joints. This shift indicates a deliberate move to position photoacoustic imaging as their defining specialty, with nanoparticle contrast enhancement emerging as a technical differentiator.

They are converging toward photoacoustic imaging with engineered nanoparticle contrast agents as their signature capability, making them a strong candidate for future projects in regenerative medicine, cell therapy monitoring, or any application requiring non-invasive deep-tissue visualization.

How they like to work

iThera Scientific joins projects as a specialist technology contributor rather than a project driver — they have no coordinator roles across either H2020 project, participating once as a full partner and once as a third party. This pattern strongly suggests they are brought in specifically for their imaging technology, with other consortium members handling clinical, biological, or administrative leadership. For future collaborators, this means engaging them early when photoacoustic imaging infrastructure or deep-tissue visualization expertise is a defined project requirement.

Across just 2 projects, iThera Scientific connected with 15 unique consortium partners in 8 countries — an above-average network density for a 2-project portfolio, indicating participation in medium-to-large research consortia rather than small bilateral arrangements.

What sets them apart

iThera Scientific is one of very few European SMEs that combine proprietary photoacoustic imaging instruments with the research expertise to deploy them in complex biomedical studies. Their participation in projects spanning diabetes, xenotransplantation, and stem cell therapy for arthritis shows their imaging platform is adaptable across disease areas rather than locked into one clinical niche. For consortium builders needing a non-invasive deep-tissue imaging partner that can also work with nanoparticle contrast agents, they fill a specialized role that is difficult to replicate with general-purpose imaging vendors or academic groups without commercial instrument capability.

Highlights from their portfolio

• STARSTEM
  Their only directly funded H2020 project (EUR 397,500), combining gold nanostars with photoacoustic, MRI, and OCT imaging to track stem cell therapy outcomes in arthritic joints — a rare multi-modal nanoparticle imaging application in regenerative medicine.
• iNanoBIT
  A long-running project (2017–2023) where iThera contributed imaging expertise across NMR, SPECT, PET, CT, and optoacoustic modalities to an ambitious diabetes and xenotransplantation program, demonstrating their breadth as a third-party imaging technology provider.